AKT1 and breast cancer: In a study using doxorubicin-resistant MCF-7 breast cancer cells, loss of miRNA-200c was associated with decreased E-cadherin and PTEN expression, and increased ZEB1 and p-Akt expression, which ultimately caused chemoresistance [19].